Whitfield Henry J
Regent's University London, London, United Kingdom.
Mindfulness Training Ltd, London, United Kingdom.
Front Psychiatry. 2021 Dec 7;12:727572. doi: 10.3389/fpsyt.2021.727572. eCollection 2021.
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major depressive disorder). The psychotherapeutic treatments accompanying these psychedelics have not been well-studied and remain controversial. This article reviews the challenges unique to psychedelic-assisted therapy and introduces a newly optimised psychological flexibility model that adapts Contextual Behavioural Science (CBS)/Acceptance and Commitment Therapy (ACT) to those multiple challenges, including ego inflation, traumatic memories, and the perceived presence of . A methodology aligned with biological mechanisms, psychological processes and therapeutic contexts may be advantageous for improving outcomes. This model expands ACT by integrating practices and data from psychedelic-assisted therapy research into a Contextual Behavioural Science framework, allowing both fields to inform each other. Psychological flexibility processes are questioned and adapted to a psychedelic context, and interventions that operationalise these processes are considered. The principle through-line of the paper is to consider varied constructs of Self, as understood by these fields, and integrates respective elements of varied self-models, interventions and data into a Spectrum of Selves model for psychedelic-assisted therapy. Secondly the paper examines how to select and retain new self-perspectives and their corresponding behaviours systemically, drawing from evolutionary science principles. A case example of such behavioural reinforcement is provided, as well as a psychedelic integration checklist to guide the practical implementation of such an approach. This method can enable a coherent therapeutic framework with clear operational relationships between (1) problematic behaviour patterns that an individual wishes to address (2) the guided psychedelic experiences of that individual, and (3) the barriers to maintaining any changes, thus increasing theoretical-practical coherence, broadening treatment benefits and reducing relapse in psychedelic-assisted therapy. Research questions for further developing a CBS-consistent psychedelic-assisted therapy are offered.
在美国,用于治疗抑郁症和创伤后应激障碍(PTSD)的迷幻剂辅助疗法研究进展迅速,美国食品药品监督管理局(FDA)已授予3,4-亚甲基二氧甲基苯丙胺(MDMA,用于创伤后应激障碍)和裸盖菇素(用于重度抑郁症)突破性认定。伴随这些迷幻剂的心理治疗方法尚未得到充分研究,仍存在争议。本文回顾了迷幻剂辅助疗法所特有的挑战,并介绍了一种新优化的心理灵活性模型,该模型将情境行为科学(CBS)/接纳与承诺疗法(ACT)应用于这些多重挑战,包括自我膨胀、创伤记忆以及感知到的……的存在。一种与生物学机制、心理过程和治疗背景相一致的方法可能有利于改善治疗效果。该模型通过将迷幻剂辅助疗法研究中的实践和数据整合到情境行为科学框架中来扩展ACT,使这两个领域能够相互借鉴。心理灵活性过程受到质疑并适用于迷幻情境,并考虑了将这些过程付诸实践的干预措施。本文的主要原则是考虑这些领域所理解的不同自我结构,并将不同自我模型、干预措施和数据的各自元素整合到一个用于迷幻剂辅助疗法的自我光谱模型中。其次,本文从进化科学原理出发,研究如何系统地选择和保留新的自我视角及其相应行为。提供了一个这种行为强化的案例示例,以及一份迷幻剂整合清单,以指导这种方法的实际应用。这种方法可以建立一个连贯的治疗框架,在(1)个体希望解决的问题行为模式、(2)该个体的引导性迷幻体验以及(3)维持任何改变的障碍之间建立明确的操作关系,从而提高理论与实践的连贯性,扩大治疗益处并减少迷幻剂辅助疗法中的复发。本文还提出了进一步发展与CBS一致的迷幻剂辅助疗法的研究问题。